Abstract B85: Tertiary lymphoid structures in chemotherapy-treated and untreated lung squamous cell carcinoma patients

Author(s):  
Karina Silina ◽  
Alex Soltermann ◽  
Holger Moch ◽  
Aija Line ◽  
Maries van den Broek
2020 ◽  
Vol 108 (4) ◽  
pp. 1307-1318
Author(s):  
Luciana Rodrigues Carvalho Barros ◽  
Paulo Thiago De Souza‐Santos ◽  
Marco Antonio Marques Pretti ◽  
Gustavo Fioravanti Vieira ◽  
Marcelo Alves De Souza Bragatte ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Ayana T. Ruffin ◽  
Anthony R. Cillo ◽  
Tracy Tabib ◽  
Angen Liu ◽  
Sayali Onkar ◽  
...  

AbstractCurrent immunotherapy paradigms aim to reinvigorate CD8+ T cells, but the contribution of humoral immunity to antitumor immunity remains understudied. Here, we demonstrate that in head and neck squamous cell carcinoma (HNSCC) caused by human papillomavirus infection (HPV+), patients have transcriptional signatures of germinal center (GC) tumor infiltrating B cells (TIL-Bs) and spatial organization of immune cells consistent with tertiary lymphoid structures (TLS) with GCs, both of which correlate with favorable outcome. GC TIL-Bs in HPV+ HNSCC are characterized by distinct waves of gene expression consistent with dark zone, light zone and a transitional state of GC B cells. Semaphorin 4a expression is enhanced on GC TIL-Bs present in TLS of HPV+ HNSCC and during the differentiation of TIL-Bs. Our study suggests that therapeutics to enhance TIL-B responses in HNSCC should be prioritized in future studies to determine if they can complement current T cell mediated immunotherapies.


Sign in / Sign up

Export Citation Format

Share Document